These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 35127393)

  • 1. A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer.
    Sun D; Zou Y; Song L; Han S; Yang H; Chu D; Dai Y; Ma J; O'Driscoll CM; Yu Z; Guo J
    Acta Pharm Sin B; 2022 Jan; 12(1):378-393. PubMed ID: 35127393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of natural products in cancer immunotherapy.
    Dong S; Guo X; Han F; He Z; Wang Y
    Acta Pharm Sin B; 2022 Mar; 12(3):1163-1185. PubMed ID: 35530162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy.
    Ma X; Yang S; Zhang T; Wang S; Yang Q; Xiao Y; Shi X; Xue P; Kang Y; Liu G; Sun ZJ; Xu Z
    Acta Pharm Sin B; 2022 Jan; 12(1):451-466. PubMed ID: 35127398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The copper (II) complex of salicylate phenanthroline induces immunogenic cell death of colorectal cancer cells through inducing endoplasmic reticulum stress.
    Chen M; Wang D; Fan L; Niu D; Xu J; Liu Y; Liu Y
    Int Immunopharmacol; 2024 May; 132():111980. PubMed ID: 38555819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti-cancer evaluation of peritumoral hydrogel injection combined with PD-L1 antibody.
    Wu H; Wei G; Luo L; Li L; Gao Y; Tan X; Wang S; Chang H; Liu Y; Wei Y; Song J; Zhang Z; Huo J
    Biomater Res; 2022 Dec; 26(1):77. PubMed ID: 36494759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer.
    Zou Y; Xiao F; Song L; Sun B; Sun D; Chu D; Wang L; Han S; Yu Z; O'Driscoll CM; Guo J
    Int J Pharm; 2021 Sep; 606():120888. PubMed ID: 34271152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic Cell Death Induced by Ginsenoside Rg3: Significance in Dendritic Cell-based Anti-tumor Immunotherapy.
    Son KJ; Choi KR; Lee SJ; Lee H
    Immune Netw; 2016 Feb; 16(1):75-84. PubMed ID: 26937234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma.
    Guo J; Yu Z; Sun D; Zou Y; Liu Y; Huang L
    Mol Cancer; 2021 Jan; 20(1):10. PubMed ID: 33407548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring in vivo combinatorial chemo-immunotherapy: Addressing p97 suppression and immune reinvigoration in pancreatic cancer with tumor microenvironment-responsive nanoformulation.
    Lo YL; Li CY; Chou TF; Yang CP; Wu LL; Chen CJ; Chang YH
    Biomed Pharmacother; 2024 Jun; 175():116660. PubMed ID: 38701563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological drug and drug delivery-mediated immunotherapy.
    Xiao Q; Li X; Li Y; Wu Z; Xu C; Chen Z; He W
    Acta Pharm Sin B; 2021 Apr; 11(4):941-960. PubMed ID: 33996408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells.
    Zhu Y; Wang A; Zhang S; Kim J; Xia J; Zhang F; Wang D; Wang Q; Wang J
    J Adv Res; 2023 Jul; 49():159-173. PubMed ID: 36167294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic gene modified cell based cancer vaccines.
    Kozłowska A; Mackiewicz J; Mackiewicz A
    Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoding cell death signals in liver inflammation.
    Brenner C; Galluzzi L; Kepp O; Kroemer G
    J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An innovative nanoformulation utilizing tumor microenvironment-responsive PEG-polyglutamic coating and dynamic charge adjustment for specific targeting of ER stress inducer, microRNA, and immunoadjuvant in pancreatic cancer: In vitro investigations.
    Li CY; Chou TF; Lo YL
    Int J Biol Macromol; 2024 Jan; 254(Pt 2):127905. PubMed ID: 37939778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanodelivery of scutellarin induces immunogenic cell death for treating hepatocellular carcinoma.
    Li L; Zou Y; Wang L; Yang L; Li Y; Liao A; Chen Z; Yu Z; Guo J; Han S
    Int J Pharm; 2023 Jul; 642():123114. PubMed ID: 37301243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembled FeS-based cascade bioreactor with enhanced tumor penetration and synergistic treatments to trigger robust cancer immunotherapy.
    Ren H; Yong J; Yang Q; Yang Z; Liu Z; Xu Y; Wang H; Jiang X; Miao W; Li X
    Acta Pharm Sin B; 2021 Oct; 11(10):3244-3261. PubMed ID: 34729313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano co-delivery of Plumbagin and Dihydrotanshinone I reverses immunosuppressive TME of liver cancer.
    Han S; Bi S; Guo T; Sun D; Zou Y; Wang L; Song L; Chu D; Liao A; Song X; Yu Z; Guo J
    J Control Release; 2022 Aug; 348():250-263. PubMed ID: 35660631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression.
    Kim M; Lee JS; Kim W; Lee JH; Jun BH; Kim KS; Kim DE
    J Control Release; 2022 Aug; 348():893-910. PubMed ID: 35760233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.